Why the study?
Does rhIGF-I improve metabolic control and physical growth in a patient with leprechaunism?
Does rhIGF-I improve metabolic control and physical growth in a patient with leprechaunism?
Long-term high-dose rhIGF-I therapy effectively prevents postnatal growth retardation and normalizes glucose metabolism in a patient with leprechaunism.
No takes yet. Share an insight, caveat, or question.
May support rhIGF-I in leprechaunism; single case leaves open generalizability and need for controlled trials.
Nakae et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: